Mereo BioPharma (AgeTech UK) Biomed
Kinase inhibitors and other in pipeline for various, inclusing COPD. Mission is to provide new therapies to patients with chronically debilitating and life limiting rare diseases that have few, if any, other treatment options.
Funding Status:
N/A
Industry:
UK AgeTech 2020
Number Of Exists:
N/A
Technology:
AgeTech Companies
Founded Date:
N/A
Investor Type:
N/A
Headquarters:
United Kingdom
Employee Number:
N/A
Investment Stage:
N/A